Stifel Upgrades ChemoCentryx (CCXI) to Buy on Amendment To Avacopan NDA
Tweet Send to a Friend
Stifel analyst Dae Gon Ha upgraded ChemoCentryx (NASDAQ: CCXI) from Hold to Buy with a price target of $31.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
